Sherry L. Ralston

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Soderstrom et al. · Cancer Research · 2005 · 135 citations · Full text

Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications

Kristin Fabre, Brian R. Berridge, William R. Proctor et al. · Lab on a Chip · 2020 · 105 citations

Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol

Gary D. Stoner, Bruce C. Casto, Sherry L. Ralston et al. · Carcinogenesis · 2002 · 79 citations · Full text

Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor

Jitesh P. Jani, Richard S. Finn, Mary E. Campbell et al. · Cancer Research · 2007 · 76 citations · Full text

Breast Oncology, Pharmacotherapy, Tumor Biology +18

Towards in vitro models for reducing or replacing the use of animals in drug testing

David M. Stresser, Anna K. Kopec, Philip Hewitt et al. · Nature Biomedical Engineering · 2023 · 75 citations

Animal Testing, Xenotransplantation, Preclinical Drug Evaluation +11